Receiving and storing COVID-19 Vaccine Moderna at PCN designated Sites

Sue Dickinson, Director of Pharmacy, Regional Drug & Therapeutics Centre (Newcastle)Published Last updated See all updates

Standard Operating Procedure for PCN designated sites receiving and storing the Moderna Spikevax® COVID-19 Vaccine

Information

A standard operating procedure  is attached to this page

Your should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using this SOP.

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in community pharmacy settings

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional who needs further advice, get in touch with us. We answer questions about Medicines Optimisation issues, including those about the COVID-19 vaccination programme. Help us to help you: tell us where on our site you were.

Change history

  1. Section 4.2 addition to clarify wholesaler responsibility regarding transit time greater than 6 hours to delivery
  1. Current content remains accurate
  1. Current content still accurate
  1. The name of the vaccine has changed to Spikevax®
  1. Reworked to reflect the fact that PCNs will receive thawed Moderna COVID-19 vaccine
  1. Published